Methylation suppresses the proteasome-inhibitory function of green tea polyphenols

Kristin R Landis-Piwowar1, Sheng Biao Wan, Richard A Wiegand

  • 1The Prevention Program, Barbara Ann Karmanos Cancer Institute, Department of Pathology, School of Medicine, Wayne State University, Detroit, Michigan, USA.

Insights

Methylation of green tea polyphenols (GTPs) reduces their ability to inhibit proteasomes, potentially lowering their cancer-preventive effects in the body. This study investigated how methylation impacts GTPs

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Cancer Prevention Research

Background:

  • Green tea polyphenols (GTPs) show cancer-preventive activity, but biotransformation, like methylation, can alter their efficacy in vivo.
  • Previous studies suggest methylated polyphenols are less cancer-protective, but the underlying molecular mechanisms remain unclear.
  • Ester bond-containing GTPs, such as (-)-epigallocatechin-3-gallate [(-)-EGCG] and (-)-epicatechin-3-gallate [(-)-ECG], are known potent inhibitors of proteasomal chymotrypsin-like activity.

Purpose of the Study:

  • To investigate the hypothesis that methylated GTPs exhibit reduced proteasome-inhibitory abilities compared to their unmethylated counterparts.
  • To elucidate the structure-activity relationships (SARs) of methylated GTP analogs concerning proteasome inhibition.

Main Methods:

  • Synthesis of methylated (-)-EGCG and (-)-ECG analogs found in vivo.
  • Assessment of proteasome-inhibitory abilities using a purified 20S proteasome and in silico docking analysis.
  • Evaluation of intracellular effects using peracetate-protected methylated GTPs in cultured human leukemic Jurkat T cells, assessing proteasome inhibition and apoptosis.

Main Results:

  • The addition of methyl groups to (-)-EGCG and (-)-ECG progressively decreased their proteasome inhibitory potency.
  • Monomethylated (-)-EGCG analogs showed greater intracellular proteasome inhibition and apoptosis induction than trimethylated analogs in Jurkat T cells.
  • In silico docking analysis supported the observed SARs, correlating methylation with reduced proteasome inhibition.

Conclusions:

  • Methylation of GTPs significantly diminishes their capacity to inhibit proteasomal activity.
  • This reduction in proteasome inhibition by methylated GTPs may explain their decreased cancer-preventive effects observed in vivo.
  • The findings highlight the critical role of GTP structure modification by methylation in modulating their biological activity and potential therapeutic benefits.

Related Concept Videos

Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase01:27

Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase

Phase II biotransformation reactions are essential for detoxifying and eliminating xenobiotics, including many pharmaceutical compounds. These reactions typically involve conjugation, the covalent attachment of polar endogenous groups such as glucuronic acid, sulfate, methyl, or acetyl moieties to functional groups introduced during Phase I metabolism. The resulting conjugates are more water-soluble, enabling efficient renal or biliary excretion.The major classes of Phase II enzymes include...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
Phase II Reactions: Methylation Reactions01:17

Phase II Reactions: Methylation Reactions

Methylation is a phase II biotransformation process involving the attachment of a methyl group to a substrate. Enzymes known as methyltransferases orchestrate this reaction.
The mechanism of methylation unfolds in two stages. The first stage sees a methyltransferase enzyme facilitating the transfer of a methyl group from S-adenosylmethionine (SAM) to the substrate, forming S-adenosylhomocysteine (SAH). The second stage involves further metabolism of SAH into homocysteine, which can be recycled...
Epigenetic Regulation01:37

Epigenetic Regulation

Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...